The Major Histocompatibility Complex Class I (MHC-I), including isoforms such as HLA-B, is fundamental in presenting peptide epitopes on the surface of cancer cells, facilitating their recognition by CD8 T cells, and mobilizing their cytotoxic response against malignancies (101–104). Here, HLA-B is linked to cancer.